Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

30,178 total articles

U.S. Agencies Say Chinese AI Firms Conducted Large-Scale Model Extraction

U.S. Agencies Say Chinese AI Firms Conducted Large-Scale Model Extraction

A joint advisory from U.S. security agencies accused several Chinese AI companies of systematically extracting capabilities from advanced U.S. AI models at scale. The agencies said the operations used multiple technical and procedural workarounds to acquire billions of tokens and that the campaigns likely occurred with awareness of Chinese governme…

NSE Set to Cut IPO Price Range, Reduce Share on Offer as Sellers Retreat

NSE Set to Cut IPO Price Range, Reduce Share on Offer as Sellers Retreat

The National Stock Exchange of India is preparing to lower the proposed price band for its initial public offering to between ₹1,700 and ₹1,785 a share and to trim the stake for sale to about 5.5% of equity, according to people familiar with the discussions. Those changes would reduce the proceeds the selling shareholders can raise and cut the impl…

U.S. Futures Tepid as Brent Nears $100 and Fed Hike Odds Climb

U.S. Futures Tepid as Brent Nears $100 and Fed Hike Odds Climb

U.S. stock futures were largely unchanged on Tuesday night following a down day on Wall Street, as Brent crude approached $100 a barrel amid Middle East tensions. The jump in oil prices has heightened inflation concerns, pushed up benchmark Treasury yields and strengthened market odds of a Federal Reserve rate increase in September ahead of this we…

Evommune Shares Plunge After EVO756 Fails to Hit Trial Goals; Company Reprioritizes Atopic Dermatitis Program

Evommune Shares Plunge After EVO756 Fails to Hit Trial Goals; Company Reprioritizes Atopic Dermatitis Program

Evommune Inc reported that its oral candidate EVO756 did not achieve the primary endpoint or secondary endpoints in a randomized, double-blind, placebo-controlled Phase 2b trial in adults with moderate-to-severe atopic dermatitis, triggering a 27% drop in after-hours trading. The company will not pursue EVO756 for atopic dermatitis and will instead…

Assembly Biosciences Opts Into 40% U.S. Profit Share on Gilead HSV Program; Shares Jump After-Hours

Assembly Biosciences Opts Into 40% U.S. Profit Share on Gilead HSV Program; Shares Jump After-Hours

Assembly Biosciences announced it exercised its contractual option to take a 40% share of U.S. development costs and profits for a herpes simplex virus helicase-primase inhibitor program run with Gilead Sciences, sending its stock up 4.9% in after-hours trading. The program centers on two investigational compounds, GS-1179 and GS-5366, and Assembly…

Blackstone Initiates Sale Process for ZO Skin Health, Sources Say

Blackstone Initiates Sale Process for ZO Skin Health, Sources Say

Blackstone has begun exploring a sale of medical-grade skincare brand ZO Skin Health, with the company’s value in any potential transaction estimated at about $2 billion, according to people familiar with the matter. The firm has engaged Citigroup and Raymond James to advise on the early-stage process; representatives for the parties did not provid…

Chime to Acquire Stride Bank for $590 Million; Shares Jump After Hours

Chime to Acquire Stride Bank for $590 Million; Shares Jump After Hours

Chime Financial said it has signed a definitive agreement to buy Stride Bank for $590 million in cash. The acquisition, which would convert Stride into a wholly owned subsidiary called Chime Bank, is expected to be accretive to earnings per share on closing, generate more than $100 million in net synergies and be funded from Chime's existing cash b…

Nike Investors Reject Measure Seeking Greater Climate Disclosure

Nike Investors Reject Measure Seeking Greater Climate Disclosure

Nike shareholders on Tuesday declined a resolution that would have required the company to disclose more granular information about its climate objectives and the strategies intended to achieve emissions reductions. The vote leaves intact management control over sustainability disclosures even as the company navigates financial pressures, political…

Cognition AI Secures $2 Billion in Series E, Valued at $48 Billion

Cognition AI Secures $2 Billion in Series E, Valued at $48 Billion

Cognition AI Inc. announced a $2 billion Series E round that places the artificial intelligence software company at a $48 billion valuation. The financing was led by new investors Andreessen Horowitz and Accel alongside a broad syndicate of existing backers. The startup reported run-rate revenue climbing from $492 million to nearly $900 million sin…

Options Activity Skews Bullish on AEO Ahead of Quarterly Report

Options Activity Skews Bullish on AEO Ahead of Quarterly Report

Options traders heavily favored calls over puts in AEO ahead of the company’s earnings report, with 27,917 contracts traded by 2:30 PM ET and a 2.1:1 call/put ratio. The most active position is the Sept. 18 $17.50 call, only $0.39 above the stock’s $17.11 market price as of Sep. 8, 2:59 PM EDT. Options imply a roughly ±13% move for the post-close S…